The DST Knockout HT29 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population derived from the HT29 human colorectal adenocarcinoma epithelial cell line, designed for the disruption of the DST gene locus. This polyclonal cell pool, generated via CRISPR/Cas9-mediated gene disruption, provides a robust loss-of-function model to investigate Dystonin function without selection or isolation of individual clones. The heterogeneous nature of the population captures a range of editing outcomes, enabling studies that reflect the biological variability of gene knockout in a cellular context.
The HT29 host cell line is a widely utilized model of intestinal epithelial adenocarcinoma, established from a primary colorectal tumor. These cells exhibit characteristic epithelial morphology, form polarized monolayers, and retain the capacity to differentiate into mucus-secreting goblet cells under appropriate culture conditions. HT29 cells are commonly employed to study colorectal cancer biology, epithelial barrier function, tumor cell adhesion, and metastatic behavior, making them an ideal background for investigating cytoskeletal and adhesion-related genes.
The DST gene encodes Dystonin, a giant cytoskeletal linker protein of the plakin family that integrates the intermediate filament network with actin microfilaments and microtubules. DST functions downstream of the transcription factor TP63 in epithelial stratification and is regulated by TGFB1 and mechanical stress signals. DST directly interacts with PLEC (plectin), ITGB4 (integrin ??4), KRT5 and KRT14 (keratins 5 and 14), COL17A1 (collagen type XVII), ACTN (actinin), and TUBB (tubulin beta) to orchestrate the assembly of hemidesmosomes and focal adhesions. Through these interactions, DST maintains epithelial architecture, modulates integrin signaling, and facilitates wound healing by coordinating cytoskeletal reorganization and cell migration.
Disruption of DST in the HT29 adenocarcinoma background abolishes its linker function, leading to compromised hemidesmosome stability and focal adhesion dynamics. This genetic perturbation results in diminished epithelial integrity, altered cell-substrate adhesion, and impaired collective migration, recapitulating aspects of skin fragility disorders such as epidermolysis bullosa simplex and hereditary sensory and autonomic neuropathy type VI. The polyclonal knockout population serves as a physiologically relevant model to dissect the contributions of DST to colorectal cancer progression, particularly in processes involving epithelial-to-mesenchymal transition and metastatic dissemination.
Researchers can employ these DST knockout polyclonal HT29 cells in a variety of experimental contexts to explore the molecular underpinnings of epithelial cancer cell behavior. Representative applications include quantitative migration and invasion assays using Transwell chambers or Matrigel-coated inserts, assessment of epithelial barrier function via transepithelial electrical resistance (TEER) measurements, immunofluorescence localization of adhesion complex components, and wound healing scratch assays. In addition, these cells are suitable for western blotting and RT?qPCR analyses to validate downstream effectors of DST signaling. For further technical details, quotations, or to discuss customization options, please contact Ascent Research.
